Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL1704553

FC(F)(F)c1ccc2oc(SCCN3CCNCC3)nc2c1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TMEM97 Q5BJF2 3/20 0.48
LMNA P02545 2/20 0.41
ALDH1A1 P00352 2/20 0.40
KDM4E B2RXH2 1/20 0.40
SOAT1 P35610 3/20 0.39
NPC1 O15118 1/20 0.39
HPGD P15428 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HRH4 Q9H3N8 1/20 0.38
PTGES O14684 1/20 0.38
HIF1A Q16665 1/20 0.37
AKR1B1 P15121 1/20 0.36
MEN1 O00255 1/20 0.36
HTT P42858 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL1705470 0.86 SOAT1 (0.52) LMNAALDH1A1SOAT1NPC1HPGD
Trifluoroacetic Acid SCHEMBL6280105 0.80 SOAT1 (0.53) TMEM97LMNAALDH1A1SOAT1HPGD
Trifluoroacetic Acid SCHEMBL5623338 0.79 ALDH1A1 (0.40) TMEM97LMNAALDH1A1KDM4ESOAT1
Trifluoroacetic Acid SCHEMBL6279616 0.78 SOAT1 (0.54) LMNAALDH1A1KDM4ESOAT1HRH4
SCHEMBL13755906 0.74 DDAH1 (0.56) TMEM97ALDH1A1SOAT1HPGDMEN1
SCHEMBL11123547 0.74 LMNA (0.51) LMNAALDH1A1NPC1HPGDRAB9A
Trifluoroacetic Acid SCHEMBL6282854 0.73 KDM4E (0.41) ALDH1A1KDM4ESOAT1NPC1RAB9A
Hydrochloric Acid SCHEMBL1705421 0.73 DDAH1 (0.55) TMEM97ALDH1A1SOAT1HPGDMEN1
Trifluoroacetic Acid SCHEMBL6282990 0.72 SOAT1 (0.48) LMNAALDH1A1KDM4ESOAT1NPC1
SCHEMBL1704601 0.72 SOAT1 (0.78) TMEM97LMNAALDH1A1KDM4ESOAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8518936-B2 Method for preparing acid addition salts of polyacidic basic compounds KOWA CO., LTD. (JP) 2013-08-27 US disclosed
EP-1598346-B1 PROCESS FOR PRODUCING ACID ADDUCT SALT OF POLYACIDIC BASE COMPOUND KOWA CO (JP) 2012-04-18 EP disclosed
US-20100234599-A1 METHOD FOR PREPARING ACID ADDITION SALTS OF POLYACIDIC BASIC COMPOUNDS KOWA CO., LTD. (JP) 2010-09-16 US disclosed
US-7750150-B2 Process for producing acid adduct salt of polyacidic base compound KOWA CO., LTD. (JP) 2010-07-06 US disclosed
US-20060079688-A1 Process for producing acid adduct salt of polyacidic base compound KOWA CO., LTD. (JP) 2006-04-13 US disclosed
EP-1598346-A1 PROCESS FOR PRODUCING ACID ADDUCT SALT OF POLYACIDIC BASE COMPOUND Kowa Co., Ltd. (JP) 2005-11-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234599-A1 METHOD FOR PREPARING ACID ADDITION SALTS OF POLYACIDIC BASIC COMPOUNDS PGA5, NAAA, CA6 TMEM97 4599/4885LMNA 950/4885ALDH1A1 1557/4885
US-20060079688-A1 Process for producing acid adduct salt of polyacidic base compound CA5B, ASIC1, NAAA TMEM97 4538/4885LMNA 1421/4885ALDH1A1 1334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.